1,4-Diacetyl-2,5-Piperazinedione

C8H10N2O4

3,9-Bis(2-Cyanoethyl)-2,4,8

C13H18N2O4

2,5-Dimethoxy-1,4-Benzoquinone

C8H8O4

2,2'-Thiobis(4-Tert-Octylpheno

C28H42O2S

1,4-Bis(4-Aminophenoxy)Benzene

C18H16N2O2

2,3-Dichloropropionic Acid-Methyl Ester

C4H6Cl2O2

2-Phenylethyl Methacrylate

C12H14O2

LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

SODIUM HYALURONATE (HA-EP 2.4)

APIXABAN FORM H3

TORSEMIDE USP

Methyl 3-Methoxypropionate, 99+%

C5H10O3

Gallic Acid Iso-Butyl Ester

C11H14O5

2,3-Dimethoxybenzyl Chloride

C9H11ClO2

1,3-Thiazole-4-Carboxylic Acid

C4H3NO2S

Maleic Acid Monoethyl Ester

C6H8O4

1-[(Trimethylsilyl)Ethynyl]-3,5-Dimethox

C13H18O2Si

4-Chloro-1,8-Naphthalic Anhydride, >=95.

C12H5ClO3

1,2:3,4-Di-O-Isopropylidene-D-Galacto-Py

C12H20O6

1,2,3,4-Tetramethyl-1,3-Cyclopentadiene

C9H14

2,2,4,4,6,8,8-Heptamethylnonane

C16H34

CLOTRIMAZOLE USP

ENHANCER S50

ROSUVASTATIN CALCIUM INTERMEDIATE (R1)

CYTISINE

4-(Trifluoromethoxy)Phenylacetic Acid

C9H7F3O3

Polyacrylamide, Average Mw Ca. 10,000

3,4-Methylenedioxyphenylacetonitrile

C9H7NO2

(R,R,R)-1-(3,5-Dioxa-4-Phospha-Cyclohep

C36H28NO2P

2-(P-Tolyl)Pyridine, 97+%

C12H11N

Vinylboronic Acid 2-Methyl-2,4-Pentaned

C8H15BO2

2,2-Bis(Hydroxymethyl)Propionic Acid

C5H10O4